Filing Details

Accession Number:
0001493152-22-023383
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 20:20:57
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 20:20:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1229339 D Alfred Kingsley 150 E. 57Th Street
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2022-08-15 10,000 $0.00 404,111 No 4 A Direct
Common Stock, No Par Value Acquisiton 2022-08-15 5,000 $0.97 409,111 No 4 P Direct
Common Stock, No Par Value Acquisiton 2022-08-15 5,000 $0.97 414,111 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Acquisiton 2022-08-15 45,000 $0.00 45,000 $0.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,000 2032-08-15 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, No Par Value 75,345 Indirect See footnote
Common Stock, No Par Value 18,767 Indirect See footnote
Footnotes
  1. The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
  2. The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.
  3. The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.
  4. Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.